Trading on the Tel Aviv Stock Exchange (TASE) during the last week was marked by high volatility and price gains in most leading indices.
The TA-25 index which decreased 0.5% over the week is now 4.2% lower than its level at the beginning of the year. This follows a sharp increase of 75% in 2009.
The TA-100 slightly raised 0.2% this week, and is now lower by 3.7% year-to-date, following an increase of 89% in 2009.
The Tel-Tech 15 index increased 1.7%, followed by the index of large real estate companies (Estate-15) and the index of large financial services companies (Finance-15) raised 0.5% and 0.2%, respectively.
The shares of U.S biomed firm, Prolor Biotech, began trading on the TASE this week. The company is already traded on NYSE AMEX and joins the 45 companies dually-listed on major U.S. exchanges and TASE. Prolor Biotech will be the third largest company of the 42 Biomed companies listed on the TASE.
Public issues based on the annual financial statements for 2009 ended this week. During January to May 2010, public companies raised about $ 1.1 billion in the stock market, compared with $ 1.7 billion in all of 2009.
Figures released by Israel’s Central Bureau of Statistics indicate that unemployment rate descended to 7.2% in the first quarter of 2010, compared to 7.6% in the parallel quarter last year and the average of 2009.
